SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041593
Filing Date
2023-08-11
Accepted
2023-08-11 07:11:33
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acrv-20230630.htm   iXBRL 10-Q 2925514
2 EX-10.2 acrv-ex10_2.htm EX-10.2 25501
3 EX-31.1 acrv-ex31_1.htm EX-31.1 19454
4 EX-31.2 acrv-ex31_2.htm EX-31.2 19435
5 EX-32.1 acrv-ex32_1.htm EX-32.1 13081
6 EX-32.2 acrv-ex32_2.htm EX-32.2 13064
  Complete submission text file 0000950170-23-041593.txt   9789976

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acrv-20230630_lab.xml EX-101.LAB 470343
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acrv-20230630_def.xml EX-101.DEF 262317
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acrv-20230630_pre.xml EX-101.PRE 383220
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acrv-20230630.xsd EX-101.SCH 57653
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acrv-20230630_cal.xml EX-101.CAL 53492
63 EXTRACTED XBRL INSTANCE DOCUMENT acrv-20230630_htm.xml XML 1715065
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41551 | Film No.: 231161493
SIC: 2834 Pharmaceutical Preparations